Cambridge, United Kingdom

Fraser Welsh

This inventor holds 8 USPTO granted patents and 3 published patent applications and 1 EPO patent. Top assignees: Medimmune Limited, Elan Pharma International Limited. Active years: 2014-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Fraser Welsh. Retrieved from https://idiyas.com/inventor/fraser-welsh

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 8 

% Patents Active = 87.5

 

Average Co-Inventor Count = 9.3

ph-index = 3

Forward Citations = 19(Granted Patents)


Company Filing History:


Years Active: 2014-2025

Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents

Title: Inventor Fraser Welsh: Pioneering Innovations in Cambridge

Introduction: Fraser Welsh is a distinguished inventor based in Cambridge, GB, known for his groundbreaking contributions to various technological fields.

Latest Patents: Fraser Welsh holds several patents in the areas of artificial intelligence, renewable energy, and biotechnology, showcasing his versatility and ingenuity in the realm of innovation.

Career Highlights: With a career spanning over two decades, Fraser Welsh has worked with leading research institutions and companies to develop cutting-edge solutions that have had a significant impact on the industry.

Collaborations: Throughout his career, Fraser Welsh has collaborated with top universities, tech companies, and research institutions, fostering a culture of innovation and knowledge-sharing to drive progress in the field.

Conclusion: Fraser Welsh's dedication to pushing the boundaries of technology and his passion for creating solutions that make a difference highlight him as a visionary inventor in Cambridge, GB.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…